Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Gastric juice plays a crucial role in the physiology of the stomach. The aim of this study is to evaluate associations among the pH of gastric juice, atrophic gastritis (AG), intestinal metaplasia (IM), pepsinogen, and Helicobacter pylori infection. Methods: Gastric biopsies and juice were collected from 46 subjects who underwent endoscopies at Seoul National University Bundang Hospital between November 2011 and March 2013. H. pylori, AG and IM were evaluated, and pepsinogen I or II, I/II ratio, and interleukin (IL)-1β levels were measured. Results: The mean pH of gastric juice was higher in the H. pylori-positive group (n=17) than that in the H. pylori-negative group (n=29) (4.54 vs 2.46, p=0.002). When patients were divided into pH <3 (n=28) and pH ≥3 (n=18) groups, H. pylori was lower in the pH <3 group (21.4%) than in the pH ≥3 group (61.1%) (p=0.007). The pH ≥3 group demonstrated AG and IM more frequently than the pH <3 group in the body (p=0.047 and p=0.051, respectively) but not in the antrum. There were no differences in pepsinogen I or II, I/II ratio, and IL-1β levels between the two groups. Conclusions: There is a relationship between chronic H. pylori infection and gastric juice pH ≥3, which may originate from AG and IM in the body.
Abstract
Background/Aims: Gastric juice plays a crucial role in the physiology of the stomach. The aim of this study is to evaluate associations among the pH of gastric juice, atrophic gastritis (AG), intestinal metaplasia (IM), pepsinogen, and Helicobacter pylori infection. Methods: Gastric biopsies and juice were collected from 46 subjects who underwent endoscopies at Seoul National University Bundang Hospital between November 2011 and March 2013. H. pylori, AG and IM were evaluated, and pepsinogen I or II, I/II ratio, and interleukin (IL)-1β levels were measured. Results: The mean pH of gastric juice was higher in the H. pylori-positive group (n=17) than that in the H. pylori-negative group (n=29) (4.54 vs 2.46, p=0.002). When patients were divided into pH <3 (n=28) and pH ≥3 (n=18) groups, H. pylori was lower in the pH <3 group (21.4%) than in the pH ≥3 group (61.1%) (p=0.007). The pH ≥3 group demonstrated AG and IM more frequently than the pH <3 group in the body (p=0.047 and p=0.051, respectively) but not in the antrum. There were no differences in pepsinogen I or II, I/II ratio, and IL-1β levels between the two groups. Conclusions: There is a relationship between chronic H. pylori infection and gastric juice pH ≥3, which may originate from AG and IM in the body.
참고문헌 (28)
- Waldum HL, "The regulation of gastric acid secretion: clinical perspectives", Acta Physiol (Oxf), 210, pp.239~256 (2014)[DOI]
- Berstad A, "A modified hemoglobin substrate method for the estimation of pepsin in gastric juice", Scand J Gastroenterol, 5, pp.343~348 (1970)
- Merki HS, "Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls", Gut, 29, pp.1583~1587 (1988)[DOI]
- Wilder-Smith CH, "Bactericidal factors in gastric-juice", Eur J Gastroenerol Hepatol, 4, pp.885~891 (1992)
- Kopic S, "Update on the mechanisms of gastric acid secretion", Curr Gastroenterol Rep, 12, pp.458~464 (2010)[DOI]
- Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Kong YJ, "Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis", World J Gastroenterol, 20, pp.5903~5911 (2014)[DOI]
- Rokkas T, "The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis", Helicobacter, 12(Suppl 2), pp.32~38 (2007)[DOI]
- Toyokawa T, "Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study", J Gastroenterol Hepatol, 25, pp.544~547 (2010)[DOI]
- Kang JM, "Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea", Helicobacter, 17, pp.86~95 (2012)[DOI]
- Iijima K, "Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria", Aliment Pharmacol Ther, 19, pp.1181~1188 (2004)[DOI]
- Osawa H, "Helicobacter pylori eradication induces marked increase in H+", K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa, 2006, pp.55, 152~157
- Kim MS, "Long-term follow up Helicobacter pylori reinfection rate after second-line treatment: bismuthcontaining quadruple therapy versus moxifloxacin-based triple therapy", BMC Gastroenterol, 13, pp.138~ (2013)[DOI]
- 김성은, "Effect of Helicobacter pylori Eradication on Functional Dyspepsia", Journal of Neurogastroenterology and Motility (JNM), 19(2), pp.233~243 (2013), 대한소화기 기능성질환∙운동학회
- Delgado S, "Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods", Microb Ecol, 65, pp.763~772 (2013)[DOI]
- Dixon MF, "Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
- Kishikawa H, "Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status", Helicobacter, 16, pp.427~433 (2011)[DOI]
- Yoon H, "Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics", Helicobacter, 16, pp.382~388 (2011)[DOI]
- Kim JJ, "Relationship of interleukin-1beta levels and gastroesophageal reflux disease in Korea", J Gastroenterol Hepatol, 28, pp.90~98 (2013)[DOI]
- Hoffman JS, "Rabbit and ferret parietal cell inhibition by Helicobacter species", Dig Dis Sci, 40, pp.147~152 (1995)[DOI]
- Cave DR, "Effect of a Campylobacter pylori protein on acid secretion by parietal cells", Lancet, 2, pp.187~189 (1989)
- Beales IL, "Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways", Gut, 42, pp.227~234 (1998)[DOI]
- Amedei A, "Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma", Intern Emerg Med, 9, pp.303~309 (2014)[DOI]
- Kuipers EJ, "Long-term sequelae of Helicobacter pylori gastritis", Lancet, 345, pp.1525~1528 (1995)[DOI]
- Kishikawa H, "Association between increased gastric juice acidity and sliding hiatal hernia development in humans", PLoS One, 12, pp.e0170416~ (2017)[DOI]
- El-Omar EM, "Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori", Gastroenterology, 118, pp.22~30 (2000)[DOI]
- Kiyohira K, "Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels", J Gastroenterol, 38, pp.332~338 (2003)[DOI]
- Porzionato A, "Peripheral chemoreceptors: postnatal development and cytochemical findings in sudden infant death syndrome", Histol Histopathol, 23, pp.351~365 (2008)
